Breakthrough “1+” model fast-tracks combo trials, cutting IND-to-Phase-I time 40 per cent and bagging the Global Oncology Innovation Leadership prize.

HONG KONG SAR - Media OutReach Newswire - 11 September 2025 - BeOne Medicines (BeOne)(NASDAQ: ONC; HKEX: 06160; SSE: 688235), was honored today at BIOHK 2025, the Hong ...

Supreme Court rules telecommunication towers are movable property, allowing input tax credit (ITC) under CGST Act, dismissing revenue's appeal against Delhi High Court's ...